Viewing Study NCT04398459


Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2026-01-31 @ 9:22 AM
Study NCT ID: NCT04398459
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-25
First Post: 2020-05-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory/Relapsed Autoimmune Hemolytic Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ibrutinib View
None BTK Inhibitor View
None autoimmune hemolytic anemia View
None AIHA View